Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
31 studies found for:    Open Studies | "Anus Diseases"
Show Display Options
Rank Status Study
1 Unknown  Comparison of Biofeedback vs. Botox Injection to Treat Levator Ani Syndrome
Condition: Levator Ani Syndrome With Pain and/or Constipation Symptoms.
Interventions: Behavioral: Biofeedback therapy;   Procedure: Botulinum Toxin Type A Injection
2 Recruiting Medico-economic Evaluation Comparing Intensity-Modulated Radiation Therapy (IMRT) Performed by Helical Tomotherapy and Dynamic Arc Therapy in Prostate, Cervical and Anal Canal Cancers
Conditions: Prostate Cancer;   Cervical Cancer;   Anal Canal Cancers
Intervention: Radiation: Intensity-Modulated Radiation Therapy
3 Not yet recruiting ART: Anal Squamous Cell Carcinoma: Investigation of Functional Imaging During chemoRadioTherapy
Condition: Anal Cancer
Intervention:
4 Recruiting Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure
Condition: Anal Fissure
Intervention: Drug: Nitroglycerin Ointment 0.4%
5 Recruiting Anal Cancer Radiotherapy Study
Condition: Anal Cancer
Intervention:
6 Recruiting Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies
Conditions: Anal Cancer;   Cervical Cancer;   Lung Cancer;   Lymphoma;   Nonneoplastic Condition
Interventions: Genetic: DNA analysis;   Genetic: RNA analysis;   Genetic: gene expression analysis;   Genetic: polymorphism analysis;   Other: biologic sample preservation procedure;   Other: flow cytometry;   Other: laboratory biomarker analysis;   Other: medical chart review
7 Unknown  Predictive Value of FMISO-PET, FDG-PET-CT, DWI-MRI and DCE-MRI Scans for Patients With Anal Cancer Receiving Radiotherapy +/- Chemotherapy
Condition: Anal Cancer
Intervention: Other: FMISO-PET, FDG-PET-CT and Magnetic Resonance Imaging (MRI)
8 Recruiting A Phase 1 Study in Participants With Advanced Cancer
Conditions: Advanced Cancer;   Squamous Cell Carcinoma;   Carcinoma, Squamous Cell of Head and Neck;   Lung Squamous Cell Carcinoma Stage IV;   Anal Squamous Cell Carcinoma;   Carcinoma, Non-Small-Cell Lung
Intervention: Drug: LY2606368
9 Recruiting Vectibix for the Treatment of Anal Cancer
Condition: Anal Squamous Cell Carcinoma
Intervention: Drug: panitumumab, mytomicin C, 5-FU, radiation
10 Not yet recruiting Functional Outcomes Following Anal Cancer Treatment
Condition: Anal Cancer
Intervention:
11 Unknown  Treatment of Anal Fissure by Activated Human Macrophages
Conditions: Biological Therapy for Chronic Anal Fissure;   Treatment by Biological Factors - Activated Macrophages;   Interventional Study
Intervention: Drug: Local injection of activated macrophages to anal fissure
12 Recruiting Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus
Conditions: Epidermoid Carcinoma;   Anus
Interventions: Drug: radiochemotherapy;   Drug: Panitumumab
13 Recruiting Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management
Condition: Rectal or Anal Cancer
Interventions: Radiation: endorectal brachytherapy;   Drug: concurrent capecitabine or 5-FU;   Behavioral: Questionnaires
14 Recruiting Phase I Study of Cetuximab in Combination With 5-fluoruracil, Mitomycin C and Radiotherapy in Patients With Anal Cancer Stage T2 (>4 cm) - T4 N0-3 M0 or Any T N2-3 M0
Condition: Locally Advanced Cancer in the Anal Region.
Interventions: Drug: Cetuximab;   Drug: Mitomycin C;   Drug: 5-Fluoruracil;   Radiation: Radiotherapy
15 Recruiting Malignant Progression of Anal Intra-epithelial Neoplasia in a Cohort of Patients
Conditions: Anal AIN3;   Anal Carcinoma
Intervention:
16 Recruiting International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel
Condition: Squamous Cell Carcinoma of the Anus
Interventions: Drug: Cisplatin;   Drug: 5-Fluorouracil (5-FU);   Drug: Carboplatin;   Drug: Paclitaxel
17 Recruiting Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
Conditions: HIV Infection;   Recurrent Anal Cancer;   Recurrent Breast Cancer;   Recurrent Esophageal Cancer;   Recurrent Gastric Cancer;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Non-small Cell Lung Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Salivary Gland Cancer;   Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Nasopharynx;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Verrucous Carcinoma of the Larynx;   Recurrent Verrucous Carcinoma of the Oral Cavity;   Salivary Gland Squamous Cell Carcinoma;   Stage IV Anal Cancer;   Stage IV Breast Cancer;   Stage IV Esophageal Cancer;   Stage IV Gastric Cancer;   Stage IV Non-small Cell Lung Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Salivary Gland Cancer;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Larynx;   Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Oropharynx;   Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IV Verrucous Carcinoma of the Larynx;   Stage IV Verrucous Carcinoma of the Oral Cavity;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: vorinostat;   Other: diagnostic laboratory biomarker analysis;   Other: pharmacological study;   Drug: carboplatin;   Drug: paclitaxel
18 Unknown  Measurement of Stress During Anesthesia With "Pain Detector" on Patients Receiving Atropine
Conditions: Hemorrhoids;   Fissure in Ano
Interventions: Drug: Administration of 0,7 mg of atropine;   Device: Measurement of skin conductance with Pain detector
19 Recruiting A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer
Condition: Anal Cancer
Intervention: Biological: Advaxis
20 Recruiting Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Anal Cancer
Condition: Anal Cancer
Interventions: Biological: cetuximab;   Drug: cisplatin;   Drug: fluorouracil;   Radiation: radiation therapy

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Indicates status has not been verified in more than two years